KET‐MCI: An open‐label trial of single‐dose ketamine treatment to improve depression in mild cognitive impairment.

Bibliographic Details
Title: KET‐MCI: An open‐label trial of single‐dose ketamine treatment to improve depression in mild cognitive impairment.
Authors: Fremont, Rachel, Karim, Amelia, Feder, Adriana, Naasan, Georges, Murrough, James, Berman, Julia
Source: Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Dec2024 Supplement 8, Vol. 20 Issue S8, p1-1, 1p
Database: Complementary Index
More Details
ISSN:15525260
DOI:10.1002/alz.095388
Published in:Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Language:English